These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 33016376)
1. Optimal multiwave sampling for regression modeling in two-phase designs. Chen T; Lumley T Stat Med; 2020 Dec; 39(30):4912-4921. PubMed ID: 33016376 [TBL] [Abstract][Full Text] [Related]
2. Optimal sampling for design-based estimators of regression models. Chen T; Lumley T Stat Med; 2022 Apr; 41(8):1482-1497. PubMed ID: 34989429 [TBL] [Abstract][Full Text] [Related]
3. Two-wave two-phase outcome-dependent sampling designs, with applications to longitudinal binary data. Tao R; Mercaldo ND; Haneuse S; Maronge JM; Rathouz PJ; Heagerty PJ; Schildcrout JS Stat Med; 2021 Apr; 40(8):1863-1876. PubMed ID: 33442883 [TBL] [Abstract][Full Text] [Related]
4. Multiwave validation sampling for error-prone electronic health records. Shepherd BE; Han K; Chen T; Bian A; Pugh S; Duda SN; Lumley T; Heerman WJ; Shaw PA Biometrics; 2023 Sep; 79(3):2649-2663. PubMed ID: 35775996 [TBL] [Abstract][Full Text] [Related]
5. Practical strategies for operationalizing optimal allocation in stratified cluster-based outcome-dependent sampling designs. Sauer S; Hedt-Gauthier B; Haneuse S Stat Med; 2023 Mar; 42(7):917-935. PubMed ID: 36650619 [TBL] [Abstract][Full Text] [Related]
6. Optimal sampling allocation for outcome-dependent designs in cluster-correlated data settings. Rivera-Rodriguez C; Haneuse S; Sauer S Stat Methods Med Res; 2022 Dec; 31(12):2400-2414. PubMed ID: 36039539 [TBL] [Abstract][Full Text] [Related]
7. Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model. Steven Ernest C; Nyberg J; Karlsson MO; Hooker AC J Pharmacokinet Pharmacodyn; 2014 Dec; 41(6):639-54. PubMed ID: 25308776 [TBL] [Abstract][Full Text] [Related]
8. Ranked set sampling in finite populations with bivariate responses: An application to an osteoporosis study. Azimian M; Moradi M; Jafari Jozani M; Leslie WD Stat Med; 2022 Apr; 41(8):1397-1420. PubMed ID: 35274755 [TBL] [Abstract][Full Text] [Related]
10. Two-Phase Sampling Designs for Data Validation in Settings with Covariate Measurement Error and Continuous Outcome. Amorim G; Tao R; Lotspeich S; Shaw PA; Lumley T; Shepherd BE J R Stat Soc Ser A Stat Soc; 2021 Oct; 184(4):1368-1389. PubMed ID: 34975235 [TBL] [Abstract][Full Text] [Related]
11. Optimal two-stage sampling for mean estimation in multilevel populations when cluster size is informative. Innocenti F; Candel MJ; Tan FE; van Breukelen GJ Stat Methods Med Res; 2021 Feb; 30(2):357-375. PubMed ID: 32940135 [TBL] [Abstract][Full Text] [Related]
12. Optimal sampling schedule design for populations of patients. Tam VH; Preston SL; Drusano GL Antimicrob Agents Chemother; 2003 Sep; 47(9):2888-91. PubMed ID: 12936990 [TBL] [Abstract][Full Text] [Related]
13. Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women's Health Study for breast cancer. Lee M; Chen J; Zeleniuch-Jacquotte A; Liu M BMC Med Res Methodol; 2023 May; 23(1):119. PubMed ID: 37208600 [TBL] [Abstract][Full Text] [Related]
14. Combining multiple imputation with raking of weights: An efficient and robust approach in the setting of nearly true models. Han K; Shaw PA; Lumley T Stat Med; 2021 Dec; 40(30):6777-6791. PubMed ID: 34585424 [TBL] [Abstract][Full Text] [Related]
15. Using Inverse Probability Bootstrap Sampling to Eliminate Sample Induced Bias in Model Based Analysis of Unequal Probability Samples. Nahorniak M; Larsen DP; Volk C; Jordan CE PLoS One; 2015; 10(6):e0131765. PubMed ID: 26126211 [TBL] [Abstract][Full Text] [Related]
16. On the combination of c- and D-optimal designs: General approaches and applications in dose-response studies. Holland-Letz T Biometrics; 2017 Mar; 73(1):206-213. PubMed ID: 27218478 [TBL] [Abstract][Full Text] [Related]
17. Extending the Case-Control Design to Longitudinal Data: Stratified Sampling Based on Repeated Binary Outcomes. Schildcrout JS; Schisterman EF; Mercaldo ND; Rathouz PJ; Heagerty PJ Epidemiology; 2018 Jan; 29(1):67-75. PubMed ID: 29068838 [TBL] [Abstract][Full Text] [Related]
18. Robust risk prediction with biomarkers under two-phase stratified cohort design. Payne R; Yang M; Zheng Y; Jensen MK; Cai T Biometrics; 2016 Dec; 72(4):1037-1045. PubMed ID: 27037494 [TBL] [Abstract][Full Text] [Related]
19. Two-stage sampling designs for external validation of personal risk models. Whittemore AS; Halpern J Stat Methods Med Res; 2016 Aug; 25(4):1313-29. PubMed ID: 23592716 [TBL] [Abstract][Full Text] [Related]
20. Adaptive response-dependent two-phase designs: Some results on robustness and efficiency. Yang C; Diao L; Cook RJ Stat Med; 2022 Sep; 41(22):4403-4425. PubMed ID: 35799345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]